Value-Based Pricing is gaining attention in MedTech, yet real-world implementation remains limited. I recently shared four key papers with a client that highlight both the promise and persistent barriers to scaling VBP in healthcare procurement – ranging from outdated pricing models to structural challenges in hospitals.
Stay ahead with the latest from NHTA Insights and updates shaping the future of market access, HTA and evidence strategy.
Insights
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
NHTA is a proud ENCePP partner conducting PASS and regulatory-RWE studies with Nordic data. With deep scientific expertise, we help elevate the visibility of real-world evidence in regulatory decision-making.
